The rupee devaluation has had a negative impact on the competitiveness of Pakistan’s pharmaceutical industry. The industry in Pakistan is local-market oriented due to significant barriers of entry to the export market. The devaluation makes pharma products less attractive to foreign purchasers. There are stringent regulations being placed by DRAP in terms of pricing which are somewhat affecting the industry adversely.
Pharmaceutical companies cannot meet their expenses from the current pricing structure because of which they are bound to demand an increase in price. These companies also have to import specific active pharma ingredients in order to manufacture medicine. This means it costs more to produce a pill in rupees which leads to lower margins and competitiveness in the market due to devaluation. The decrease and slowing down on the competition, however, is beneficial to the public, and to an extent, to the pharma industry. Therefore, having a rate which is feasible for both the industry and public is a better option.
Mehr Aftab
Toronto, Canada
In the Pakistan of high inflation, an ordinary person cannot pay rent as their electricity bills often exceed the...
Pakistan is at a critical juncture, with recent events highlighting the need for constructive dialogue. The Pashtun...
The long-awaited surgery of the Pakistan cricket team has begun. The first four to go are Shaheen Afridi, Babar Azam,...
The gas connection in our area is highly unreliable, with the gas supply prone to random disruptions regardless of the...
Many problems ordinary citizens in Pakistan encounter may be due to limited awareness or indifferent attitudes towards...
The recent crackdown on peaceful protestors outside the Karachi Press Club is a harsh reminder of how easily the...